Exogenous ketone supplements are growing in popularity. They are used as a means of boosting ketone levels in the blood. Here we take a look at how well popular exogenous ketone supplements can boost ketone levels.

This summary of the experiment covers the following:

  1. What Exogenous Ketone Supplements Are
  2. What the Experiment Was and Why We Did It
  3. How the Experiment Was Run
  4. The Experiment Results
  5. Cost Analysis
  6. Post Analysis – Strengths and Limitations
  7. Summary: The Takeaways

What Exogenous Ketone Supplements Are

Exogenous ketone supplements are supplements that boost levels of ketones in the blood.

Exogenous ketone supplements include ketone esters, ketone salts, MCT oils, and 1,3-butanediol.

You can also find supplements and foods that contain the above as “active ingredients”. For instance, there are MCT powders (containing C8 MCT oil or mixed MCT oil). There are also snacks and bars available (like the Ketone Bar) which contain these.

However, the ability of each powder and snack to boost ketone levels relies on the ketone ester, ketone salt, or MCT it contains. So we designed our experiment to test each of these ‘active ingredients’ in its isolated/ pure form.

What the Experiment Was and Why We Did It

We wanted to know how well each exogenous ketone supplement could boost levels of beta-hydroxybutyrate. This is also known as BHB ketone. It is the ketone body that is measured by handheld blood meters and often used in studies.

To do this, we tested blood ketone and glucose responses to the most popular exogenous ketone supplements at the time to know for sure.

How the Experiment Was Run

What Was Tested?

For the experiment, two participants took four days’ worth of baseline readings. These measured blood levels of glucose and BHB ketone.

Next, participants tested one exogenous ketone supplement per week. Seven days was left between each test as a ‘washout period’. This made sure that there were no leftover effects from one test spilling over to another.

Here are the ketone supplements that were tested:

  1. HVMN Ketone Ester (now discontinued – it was licensed from TΔS)
  2. KE4 ketone Aid Ketone Ester
  3. KetoCaNa Ketone Salt
  4. Pruvit Keto OS Max Ketone Salt (now discontinued)
  5. Ketosource Pure C8 MCT Oil

Table 1: The five ketone supplements used in the experiment and their dosages


*The HVMN and Pruvit products listed here are now discontinued
**One UK tablespoon is now known to be 15ml. This has been corrected on the nutrition label for Pure C8 MCT Oil. A dose of 18ml was used in this experiment.

How Did We Prepare For The Experiment? Who Did It?

Here are some details for the participants:

  • Two participants (one male and one female) both tested all exogenous ketone supplements one time each.
  • Both participants had been following a ketogenic diet for at least two years. They each had measurable levels of blood BHB ketones at the time of testing.

In order for the experiments to go ahead, each participant:

  • Had their final meal no later than 7.30pm the previous evening
  • Had a good amount of sleep the previous night
  • Took no food, drink or exercise upon waking

These ‘lifestyle factors’ are known to influence ketone levels. So this approach helped ensure that nothing interfered with the participants’ responses.

How Did We Do The Experiment?

Figure 1. Overview of the testing procedure

A pre-testing survey was completed by each participant before each test. This survey addressed variables that may confound the responses to the supplements. These included:

  • Sleep Quality and Duration
  • Energy Levels Compared to Normal
  • Illness
  • Weight Measurement
  • Waist Measurements
  • Current Medication
  • Time Finished Last Meal
  • Last Time to Exercise

After the survey, resting blood BHB ketone and blood glucose measurements were taken. The participants used the OnCall Dual Glucose Ketone Monitor for these measurements (we now use the Keto-Mojo meter) These baseline measurements were followed by the consumption of one exogenous ketone supplement.

Levels of blood BHB ketone and blood glucose were measured every 30 minutes. Measurements were taken for a total of three hours. Participants resumed their normal day-to-day activities after each test.

The Experiment Results

Average Blood BHB Ketone Responses

Figure 2. Average blood BHB ketone levels following consumption of each exogenous ketone supplement

As expected, we saw the ketone esters boost BHB ketone levels much higher than the ketone salts or C8 MCT oil.

On average, both the esters and salts had their maximal effects after 30-60 minutes. This is similar to results from published studies.

In contrast, it took 120 minutes on average for C8 MCT oil to do the same. This is longer than the expected results for C8 MCT oil.

One possible explanation for this is that both participants were on ketogenic diets during the experiment. On average, the participants were at or near appetite reduction ketosis at the start of each test. This is the BHB level where you can expect a reduced appetite. It is often referred to simply as ‘ketosis’ or ‘nutritional ketosis’. The participants’ baseline ketogenic metabolism may have effected their responses to C8 MCT oil.

The BHB ketone boost lasted longer for the esters compared to the salts or C8 MCT oil. BHB ketone levels returned to baseline after 120 minutes following salt consumption. But they remained boosted 180 minutes following consumption of the ester.

Average Blood Glucose Responses

Figure 3. Average blood glucose levels following consumption of each exogenous ketone supplement

We saw that the ketone esters and ketone salts reduced blood glucose levels, whereas the C8 MCT oil did not. Similar to the BHB ketone boosts, this effect was most pronounced with the ketone esters. Blood glucose levels remained lower at 180 minutes following consumption of either ketone ester.

Cost Analysis

Figure 4. The cost per serving and peak BHB ketone boosts for each exogenous ketone supplement

In general, the cost per serving for each exogenous ketone supplement tracked with its peak BHB ketone boost. Ketone esters give the highest BHB ketone boost and cost the most per serving. Salts cost much less per serving than esters but also give a smaller BHB ketone boost. C8 MCT oil costs the least per serving and boosts BHB ketones by the smallest amount.

Post Analysis – Strengths and Limitations

A wide selection of exogenous ketone supplements were tested at the recommended serving sizes.

Some of these supplements are now discontinued. So follow-up studies will be needed to continue testing popular options on the market.

Blood glucose and BHB ketone responses were recorded every 30 minutes for each test. This is consistent with similar studies.

The test duration of 180 minutes did not capture the full response to some of the exogenous ketone supplements. So follow-up studies may track responses for longer periods of time.

For example, continuous glucose monitors and continuous ketone monitors could be used. These would allow for tracking over several weeks. They could provide greater insights into the long-term effects of each supplement.

The study was most limited by the number of participants. More participants would allow for deeper analysis. Various analyses could be performed based on differences in biology and lifestyle. These could include differences in diet, body size, exercise regimen, and biological sex.

Diet may be especially important here. Both participants in this experiment were on ketogenic diets. Follow-up studies using other baseline diets could help with setting expectations for those diets.

Final Thoughts

We found that ketone esters provided the largest BHB ketone boost per serving. This is followed by ketone salts and finally C8 MCT oil. These results are similar to those in published studies.

Our cost analysis showed that, in general, you pay more for a larger BHB ketone boost. So the most cost-effective option for you depends on your target ketone level.

If your goal is fat loss, then any of the exogenous ketone supplements we tested will work. They can all help you reach appetite reduction ketosis. Check out this step-by-step guide if you’d like to use C8 MCT oil for this.

Watch the Ketone Ester Tasting Videos

Video 1: Taste Test Watch here to see the participants taste the HVMN ketone ester for the first time
https://www.youtube.com/watch?v=jwAJSidDLK4&list=UUziOg3-ynLOP7c6rLpdnUxA&index=2

Video 2: Taste Test Watch here to see the participants taste the KetoneAid ketone ester for the first time
https://www.youtube.com/watch?v=OuwWBzXEVF0&list=UUziOg3-ynLOP7c6rLpdnUxA&index=1

Summary: The Takeaways

  1. We confirmed that exogenous ketone supplements boost BHB ketone levels to varying degrees.
    • All of the exogenous ketone supplements tested boosted BHB ketone levels. Ketone esters caused the largest boost, then ketone salts, and then C8 MCT oil.
    • Ketone esters and ketone salts boosted BHB ketone levels to their peaks within 30 minutes. C8 MCT oil took longer with a peak at two hours.
  2. In general, you can expect to pay more for a higher BHB ketone boost. So the most cost-effective option for you depends on your target ketone level.
    • All of the exogenous ketone supplements we tested can help you reach appetite reduction ketosis. So you can choose any of them if your goal is fat loss.
QUESTIONS: Have you been taking Ketone Supplements or have you tried Ketone Esters? What would you like us to test next? Let us know by adding to them in the comments.

Research References

1.
Dietze G, Wicklmayr M, Grunst J, Mehnert H (1976) [The anti-ketogenic effect of fructose]. Verh Dtsch Ges Inn Med 82 Pt 1:767–769
1.
Lee BM, Wolever TM (1998) Effect of glucose, sucrose and fructose on plasma glucose and insulin responses in normal humans: comparison with white bread. Eur J Clin Nutr 52:924–928. https://doi.org/10.1038/sj.ejcn.1600666
1.
Hypometabolism as a therapeutic target in Alzheimer’s disease | SpringerLink. https://link.springer.com/article/10.1186/1471-2202-9-S2-S16. Accessed 30 Mar 2020
1.
Dietary ketosis enhances memory in mild cognitive impairment - ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S0197458010004392. Accessed 30 Mar 2020
1.
Alzheimer’s Disease is Type 3 Diabetes—Evidence Reviewed - Suzanne M. de la Monte, Jack R. Wands, 2008. https://journals.sagepub.com/doi/abs/10.1177/193229680800200619. Accessed 30 Mar 2020
1.
Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer’s disease - ScienceDirect. https://www.sciencedirect.com/science/article/pii/S2352873717300707. Accessed 30 Mar 2020
1.
Pawlosky RJ, Kashiwaya Y, King MT, Veech RL (2020) A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer’s Disease. IJMS 21:1044. https://doi.org/10.3390/ijms21031044
1.
Rafi MA, Alavi A (2017) Debate on human aging and lifespan. Bioimpacts 7:135–137. https://doi.org/10.15171/bi.2017.16
1.
Crimmins EM (2015) Lifespan and Healthspan: Past, Present, and Promise. GERONT 55:901–911. https://doi.org/10.1093/geront/gnv130
1.
Huang Y, Mark Jacquez G (2017) Identification of a Blue Zone in a Typical Chinese Longevity Region. IJERPH 14:571. https://doi.org/10.3390/ijerph14060571
1.
Poulain M, Pes GM, Grasland C, et al (2004) Identification of a geographic area characterized by extreme longevity in the Sardinia island: the AKEA study. Experimental Gerontology 39:1423–1429. https://doi.org/10.1016/j.exger.2004.06.016
1.
Metabolic Syndrome and Risk of Cancer | Diabetes Care. https://care.diabetesjournals.org/content/35/11/2402.abstract. Accessed 30 Mar 2020
1.
Esposito K, Chiodini P, Colao A, et al (2012) Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis. Diabetes Care 35:2402–2411. https://doi.org/10.2337/dc12-0336
1.
Obesity and Risk of Cancer: An Introductory Overview | SpringerLink. https://link.springer.com/chapter/10.1007/978-3-319-42542-9_1. Accessed 30 Mar 2020
1.
Seeman TE, Crimmins E, Huang M-H, et al (2004) Cumulative biological risk and socio-economic differences in mortality: MacArthur Studies of Successful Aging. Social Science & Medicine 58:1985–1997. https://doi.org/10.1016/S0277-9536(03)00402-7
1.
Pinquart M, Sörensen S (2000) Influences of socioeconomic status, social network, and competence on subjective well-being in later life: A meta-analysis. Psychology and Aging 15:187–224. https://doi.org/10.1037/0882-7974.15.2.187
1.
Orzack SH, Stubblefield JW, Akmaev VR, et al (2015) The human sex ratio from conception to birth. Proc Natl Acad Sci USA 112:E2102–E2111. https://doi.org/10.1073/pnas.1416546112
1.
Austad SN (2015) The human prenatal sex ratio: A major surprise. PNAS 112:4839–4840. https://doi.org/10.1073/pnas.1505165112
1.
Austad SN, Fischer KE (2016) Sex Differences in Lifespan. Cell Metabolism 23:1022–1033. https://doi.org/10.1016/j.cmet.2016.05.019
1.
Lemaître J-F, Ronget V, Tidière M, et al (2020) Sex differences in adult lifespan and aging rates of mortality across wild mammals. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1911999117
1.
Zanoboni A, Schwarz D, Zanoboni-Muciaccia W (1976) Stimulation of insulin secretion in man by oral glycerol administration. Metab Clin Exp 25:41–45. https://doi.org/10.1016/0026-0495(76)90158-x
1.
Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease | Cardiology | JAMA | JAMA Network. https://jamanetwork.com/journals/jama/article-abstract/2722770. Accessed 29 Mar 2020
1.
Madsen EL, Rissanen A, Bruun JM, et al (2008) Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology 158:179–187. https://doi.org/10.1530/EJE-07-0721
1.
Danesh J, Whincup P, Walker M, et al (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199–204. https://doi.org/10.1136/bmj.321.7255.199
1.
Nguyen NT, Nguyen X-MT, Wooldridge JB, et al (2010) Association of obesity with risk of coronary heart disease: findings from the National Health and Nutrition Examination Survey, 1999–2006. Surgery for Obesity and Related Diseases 6:465–469. https://doi.org/10.1016/j.soard.2010.02.038
1.
Partsalaki I, Karvela A, Spiliotis BE (2012) Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents. J Pediatr Endocrinol Metab 25:697–704. https://doi.org/10.1515/jpem-2012-0131
1.
Volek J, Phinney S, Forsythe C, et al (3) (PDF) Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet. https://www.researchgate.net/publication/23663658_Carbohydrate_Restriction_has_a_More_Favorable_Impact_on_the_Metabolic_Syndrome_than_a_Low_Fat_Diet. Accessed 26 Mar 2020
1.
Wilson PWF, D’Agostino RB, Parise H, et al (2005) Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. Circulation 112:3066–3072. https://doi.org/10.1161/CIRCULATIONAHA.105.539528
1.
Gershuni VM, Yan SL, Medici V (2018) Nutritional Ketosis for Weight Management and Reversal of Metabolic Syndrome. Curr Nutr Rep 7:97–106. https://doi.org/10.1007/s13668-018-0235-0
1.
Volek JS, Sharman MJ (2004) Cardiovascular and Hormonal Aspects of Very-Low-Carbohydrate Ketogenic Diets. Obesity Research 12:115S-123S. https://doi.org/10.1038/oby.2004.276
1.
Kosinski C, Jornayvaz F (2017) Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. Nutrients 9:517. https://doi.org/10.3390/nu9050517
1.
Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ (2019) Ketogenic Diet in Alzheimer’s Disease. IJMS 20:3892. https://doi.org/10.3390/ijms20163892
1.
Włodarek D (2019) Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease). Nutrients 11:169. https://doi.org/10.3390/nu11010169
1.
Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356942/. Accessed 19 Mar 2020
1.
Fine E Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/22840388. Accessed 19 Mar 2020
1.
Zhou W The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/17313687. Accessed 19 Mar 2020
1.
Klement Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/27159218. Accessed 19 Mar 2020
1.
Kentaro Nakamura, Hidekazu Tonouchi, Akina Sasayama, Kinya Ashida (2018) A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice. Nutrients 10:206. https://doi.org/10.3390/nu10020206
1.
Lv M, Zhu X, Wang H, et al (2014) Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis. PLoS ONE 9:e115147. https://doi.org/10.1371/journal.pone.0115147
1.
Poff AM, Ari C, Seyfried TN, D’Agostino DP (2013) The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer. PLoS ONE 8:e65522. https://doi.org/10.1371/journal.pone.0065522
1.
Poff A, Koutnik AP, Egan KM, et al (2019) Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Seminars in Cancer Biology 56:135–148. https://doi.org/10.1016/j.semcancer.2017.12.011
1.
Sremanakova A systematic review of the use of ketogenic diets in adult patients with cancer - Sremanakova - 2018 - Journal of Human Nutrition and Dietetics - Wiley Online Library. https://onlinelibrary.wiley.com/doi/abs/10.1111/jhn.12587. Accessed 19 Mar 2020
1.
Bettum IJ, Gorad SS, Barkovskaya A, et al (2015) Metabolic reprogramming supports the invasive phenotype in malignant melanoma. Cancer Letters 366:71–83. https://doi.org/10.1016/j.canlet.2015.06.006
1.
Warburg O (1956) On the Origin of Cancer Cells. Science 123:309–314. https://doi.org/10.1126/science.123.3191.309
1.
Van Wymelbeke V, Himaya A, Louis-Sylvestre J, Fantino M (1998) Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men. Am J Clin Nutr 68:226–234. https://doi.org/10.1093/ajcn/68.2.226
1.
Hellman DE, Senior B, Goodman HM (1969) Anti-lipolytic effects of β-hydroxybutyrate. Metabolism - Clinical and Experimental 18:906–915. https://doi.org/10.1016/0026-0495(69)90031-6
1.
Newport MT, VanItallie TB, Kashiwaya Y, et al (2015) A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer’s. Alzheimers Dement 11:99–103. https://doi.org/10.1016/j.jalz.2014.01.006
1.
Cavaleri F, Bashar E (2018) Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health. J Nutr Metab 2018:. https://doi.org/10.1155/2018/7195760

mm
Zach Sellers, PhD.

Zach graduated from the University of Louisville with a PhD in microbiology and immunology, where he researched the role of genomic imprinting in cancer malignancy. He holds BSc degrees in chemistry and biology from the University of Kentucky and has a strong background in biochemistry. Zach joined the Ketosource team in 2019 as a Nutrition Analyst and has since been helping design experiments and write articles for the Ketosource website. Along with helping clients navigate the keto diet, Zach has an obsession with stem cells and fasting and is excited to relay developments in these overlapping fields to the public.